Skip to content
Trial Eligibility
Menu

Family Members at INcreased-risk for Developing Inflammatory Bowel Disease

NCT06655415

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

First-degree relatives of people with inflammatory bowel disease ("IBD," including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow unaffected first-degree relatives (who do not have IBD) over time to understand if their behaviors, diet, and biomarkers for IBD can help predict who gets IBD and if IBD can be prevented in these high-risk individuals. Participants will be asked once per year to complete a questionnaire and have their blood, stool, and urine collected.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Inflammatory Bowel Disease (IBD)
  • Ulcerative Colitis (UC)
  • IBD-unclassified (IBD-U)
  • Indeterminate Colitis
  • Crohn's Disease Colon
  • Crohn's Colitis
  • Crohn's Ileocolitis
  • Crohn's Gastritis
  • Crohn's Jejunitis
  • Crohn's Duodenitis
  • Crohn's Esophagitis
  • Ulcerative Proctitis
  • Ulcerative Proctosigmoiditis

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
14 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
October 7, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.